Vulnerability Details : CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Products affected by CVE-2015-3965
- cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2015-3965
0.21%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 58 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2015-3965
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
9.0
|
HIGH | AV:N/AC:L/Au:S/C:C/I:C/A:C |
8.0
|
10.0
|
NIST | |
|
8.8
|
HIGH | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
2.8
|
5.9
|
NIST |
CWE ids for CVE-2015-3965
-
Assigned by: nvd@nist.gov (Primary)
References for CVE-2015-3965
-
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01
Hospira Symbiq Infusion System Vulnerability | CISAUS Government Resource;Third Party Advisory
Jump to